PTSD clinical trials

Explore recruiting ptsd clinical trials.

Recruiting ptsd studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

PTSD trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Pilot Study to Assess the Use of Methylone in the Treatment of PTSD IMPACT-1 (Investigation of Methylone for Post-Traumatic Stress Disorder [PTSD])

Ireland

Phase I and Phase II (Integrated)- Other EU CTIS Study details

REVERSE: a randomized controlled trial (RCT) to ameliorate treatment-resistant Post Traumatic Stress Disorder (PTSD) with Glucocorticoid Receptor (GR) antagonism

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

SHIELD – Swift Hydrocortisone Intervention after trauma exposure

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

High-Intensity Inpatient MDMA-Assisted Psychotherapy for Treatment-Refractory Posttraumatic Stress Disorder: An Open-Label Pilot Study

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Treating Nightmares in Posttraumatic Stress Disorder with the α-adrenergic Agents Clonidine and Doxazosin: A Randomized-Controlled Feasibility Study - ClonDoTrial

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Women victims of violences : PTSD treatment by traumatic memory reactivation under the influence of propranolol (VIOFEM)

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

PTSD trials by city

PTSD in Toronto PTSD in Vancouver PTSD in Montreal PTSD in Calgary PTSD in Edmonton PTSD in Ottawa PTSD in Winnipeg PTSD in Quebec City PTSD in Hamilton PTSD in Kitchener PTSD in London PTSD in Halifax PTSD in New York PTSD in Los Angeles PTSD in Chicago PTSD in Houston

Other conditions

Multiple sclerosis Epilepsy ALS Huntington's disease Peripheral neuropathy Restless legs syndrome Essential tremor Dementia Depression Anxiety Bipolar disorder Schizophrenia OCD ADHD Insomnia Postpartum depression Alcohol use disorder Substance use disorder COPD Asthma Long COVID Cystic fibrosis Pulmonary fibrosis Sleep apnea